{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:05:19Z","timestamp":1764259519066},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Hematology"],"published-print":{"date-parts":[[2004,12,1]]},"DOI":"10.1532\/ijh97.04069","type":"journal-article","created":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T02:36:07Z","timestamp":1104374167000},"page":"428-431","source":"Crossref","is-referenced-by-count":8,"title":["Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis: A Case Report"],"prefix":"10.1007","volume":"80","author":[{"given":"Korenori","family":"Ohtsubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritsuko","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michitoshi","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Yakushiji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michio","family":"Sata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"E00001","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001; 168-170."},{"key":"E00002","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-112-7-492","author":"Cooper, DJ","year":"1990","unstructured":"Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: a prospective, controlled clinical study. Ann Intern Med. 1990;112:492-498.","journal-title":"Ann Intern Med"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1200\/JCO.2000.18.21.3633","volume":"18","author":"Gutierrez, M","year":"2000","unstructured":"Gutierrez M, Chabner BA, Pearson D, et al. Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH. J Clin Oncol. 2000;18:3633-3642.","journal-title":"J Clin Oncol"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1182\/blood.V99.8.2685","author":"Wilson, WH","year":"2002","unstructured":"Wilson WH, Grossbard ML, Pittaluga S, et al. Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. Blood. 2002;99:2685-2693.","journal-title":"Blood"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ijc.2910490512","author":"Lai, G","year":"1991","unstructured":"Lai G-M, Chen Y-N, Mickley LA, et al. P-glycoprotein expression and schedule dependence of Adriamycin cytotoxicity in human colon carcinoma cell lines. Int J Cancer. 1991;49:696-703.","journal-title":"Int J Cancer"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF02982552","volume":"74","author":"Maeda, T","year":"2001","unstructured":"Maeda T, Yamada Y, Tawara M, et al. Successful treatment with a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) for a patient with relapsed mantle cell lymphoma who developed a human anti-chimeric antibody. Int J Hematol. 2001;74:70-75.","journal-title":"Int J Hematol"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.2000.18.2.317","volume":"18","author":"Foran, JM","year":"2000","unstructured":"Foran JM, Rohatiner AZ, Cunningham D, et al. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol. 2000;18:317-324.","journal-title":"J Clin Oncol"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.2002.20.5.1288","author":"Howard, OM","year":"2002","unstructured":"Howard OM, Gribben JG, Neuberg DS, et al. Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival. J Clin Oncol. 2002;20:1288-1294.","journal-title":"J Clin Oncol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/sonc.2002.30151","author":"Wilson, WH","year":"2002","unstructured":"Wilson WH, Gutierrez M, O'Connor P, et al. The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R. Semin Oncol. 2002;29:41-47.","journal-title":"Semin Oncol"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/annonc\/mdh093","author":"Jermann, M","year":"2004","unstructured":"Jermann M, Jost LM,Taverna Ch, et al. Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study. Ann Oncol. 2004;15:511-516.","journal-title":"Ann Oncol"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","author":"Weisenburger, DD","year":"1996","unstructured":"Weisenburger DD, Armitage JO. Mantle cell lymphoma: an entity comes of age. Blood. 1996;87:4483-4494.","journal-title":"Blood"},{"key":"E00012","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2141.1996.5421085.x","volume":"93","author":"Zoldan, MC","year":"1996","unstructured":"Zoldan MC, Inghirami G, Masuda Y, et al. Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome. Br J Haematol. 1996;93:475-486.","journal-title":"Br J Haematol"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2559.1994.tb00533.x","volume":"24","author":"Ott, MM","year":"1994","unstructured":"Ott MM, Ott G, Kuse R, et al. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology. 1994;24:329-334.","journal-title":"Histopathology"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","volume":"6","author":"Norton, AJ","year":"1995","unstructured":"Norton AJ, Matthews J, Pappa V, et al. Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol. 1995;6:249-256.","journal-title":"Ann Oncol"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","volume":"89","author":"Argatoff, LH","year":"1997","unstructured":"Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997;89:2067-2078.","journal-title":"Blood"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/sj.leu.2402272","author":"Bernard, M","year":"2001","unstructured":"Bernard M, Gressin R, Lefr\u00e8re F, et al. Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype. Leukemia. 2001;15:1785-1791.","journal-title":"Leukemia"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/1097-0142(20011101)92:9<2237::AID-CNCR1569>3.0.CO;2-9","author":"Sillos, EM","year":"2001","unstructured":"Sillos EM, Shenep JL, Burghen GA, Pui CH, Behm FG, Sandlund JT. Lactic acidosis: a metabolic complication of hematologic malignancies: case report and review of the literature. Cancer. 2001;92: 2237-2246.","journal-title":"Cancer"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<242::AID-AJH8>3.0.CO;2-A","author":"Mollejo, M","year":"1999","unstructured":"Mollejo M, Lloret E, Solares J, Bergua JM, Mateo M, Piris MA. Splenic involvement by blastic mantle cell lymphoma (large cell\/ anaplastic variant) mimicking splenic marginal zone lymphoma. Am J Hematol. 1999;62:242-246.","journal-title":"Am J Hematol"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1023\/A:1022490512705","author":"Mazurek, S","year":"1997","unstructured":"Mazurek S, Boschek CB, Eigenbrodt E. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr. 1997;29:315-330.","journal-title":"J Bioenerg Biomembr"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00641317","author":"Durig, J","year":"1996","unstructured":"Durig J, Fiedler W, de Wit M, Steffen M, Hossfeld DK. Lactic acidosis and hypoglycemia in a patient with high-grade non-Hodgkin's lymphoma and elevated circulating TNF-alpha. Ann Hematol. 1996;72:97-99.","journal-title":"Ann Hematol"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1056\/NEJM198011063031907","author":"Fraley, DS","year":"1980","unstructured":"Fraley DS, Adler R, Bruns FJ, Zett B. Stimulation of lactate production by administration of bicarbonate in a patient with solid neoplasm and lactic acidosis. N Engl J Med. 1980;303:1100-1102.","journal-title":"N Engl J Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1532\/IJH97.04069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T02:09:58Z","timestamp":1586052598000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1532\/IJH97.04069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,12,1]]}},"alternative-id":["WWGJY7E8TX0Q62QU"],"URL":"https:\/\/doi.org\/10.1532\/ijh97.04069","relation":{},"ISSN":["0925-5710"],"issn-type":[{"value":"0925-5710","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}